TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 50nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 55.4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 370nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 430nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 620nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 750nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 780nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.11E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.21E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.37E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.57E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.19E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.66E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.72E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
Affinity DataIC50: 2.80E+3nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.85E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 3.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 3.20E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 3.30E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 3.44E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Cistim Leuven
Curated by ChEMBL
Cistim Leuven
Curated by ChEMBL
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Affinity DataIC50: 4.20E+3nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 4.31E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 4.34E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
Affinity DataIC50: 4.40E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 4.48E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 4.50E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 4.54E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 4.76E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 5.90E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
Affinity DataIC50: 6.10E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 6.40E+3nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 6.61E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 6.64E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 6.81E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair